Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
493.53
-7.97 (-1.59%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Medpace Holdings Employees
Medpace Holdings had 6,200 employees as of December 31, 2025. The number of employees increased by 300 or 5.08% compared to the previous year.
Employees
6,200
Change (1Y)
300
Growth (1Y)
5.08%
Revenue / Employee
$408,102
Profits / Employee
$72,762
Market Cap
14.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,200 | 300 | 5.08% |
| Dec 31, 2024 | 5,900 | 0 | - |
| Dec 31, 2023 | 5,900 | 700 | 13.46% |
| Dec 31, 2022 | 5,200 | 700 | 15.56% |
| Dec 31, 2021 | 4,500 | 900 | 25.00% |
| Dec 31, 2020 | 3,600 | 100 | 2.86% |
| Dec 31, 2019 | 3,500 | 600 | 20.69% |
| Dec 31, 2018 | 2,900 | 400 | 16.00% |
| Dec 31, 2017 | 2,500 | 0 | - |
| Dec 31, 2016 | 2,500 | 300 | 13.64% |
| Dec 31, 2015 | 2,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| Mettler-Toledo International | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,080 |
MEDP News
- 2 days ago - Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately - PRNewsWire
- 11 days ago - Medpace Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 18 days ago - Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 - Business Wire
- 7 weeks ago - Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility - PRNewsWire
- 2 months ago - Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - GlobeNewsWire
- 2 months ago - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 3 months ago - Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 - Business Wire
- 5 months ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga